Oral Microbial Dynamics in the Development of Xerostomia in Elderly Populations

Singer Blaser^*
*Correspondence: Singer Blaser, Department of Applied Biology & Chemical Technology, The Hong Kong Polytechnic University, Hong Kong SAR 997700, China, Email:

Introduction

Xerostomia, commonly known as dry mouth, is a condition characterized by a reduced or absent salivary flow. It is a prevalent issue among the elderly, with numerous studies indicating that age-related factors significantly contribute to its development. Xerostomia not only leads to discomfort but can also cause a range of complications, including difficulty in swallowing, speech impediments, dental decay, and increased risk of infections in the oral cavity. The link between xerostomia and oral microbial dynamics has garnered growing attention, as recent research suggests that changes in the oral microbiome may play a key role in the onset and progression of this condition. In elderly populations, factors such as age, medication, systemic diseases, and the reduction in salivary output contribute to the modification of the oral microbial environment, thus influencing oral health and the overall development of xerostomia. This article explores the interplay between oral microbial dynamics and the development of xerostomia in the elderly, highlighting the factors involved and their clinical implications [1].

Xerostomia is often misinterpreted as a condition where there is a total lack of saliva production. However, it is more accurately characterized by a subjective sensation of dryness in the mouth, often accompanied by symptoms such as a sticky feeling in the mouth, difficulty swallowing, and soreness of the oral tissues. While the condition is common in elderly individuals, it is essential to understand that the elderly population is not homogenous, and a variety of factors contribute to the prevalence and severity of xerostomia in this age group. Age-related changes in the salivary glands, reduced efficiency of saliva production, and a higher prevalence of systemic conditions such as diabetes, hypertension, and autoimmune diseases significantly contribute to xerostomia in the elderly. Additionally, medication use, which is a common feature of aging, is one of the most significant risk factors for the development of xerostomia. Many drugs, particularly those with anticholinergic properties, reduce salivary secretion and contribute to the sensation of dry mouth [2].

Description

Saliva plays a vital role in maintaining oral health. It aids in lubricating the oral cavity, promoting digestion, and facilitating the clearance of food particles and debris from the teeth and gums. Furthermore, saliva contains antimicrobial proteins, enzymes, and antibodies that help protect the oral cavity from harmful microorganisms. Saliva also maintains the pH balance in the mouth, neutralizing acids produced by bacteria that could otherwise contribute to tooth decay. In elderly individuals, a decrease in salivary flow, whether due to natural aging processes or as a side effect of medication, can significantly impair these protective functions. As a result, the oral cavity becomes more susceptible to microbial imbalances, leading to the proliferation of pathogenic microorganisms. The changes in the microbial environment can have direct implications for the development of oral diseases, particularly in individuals with xerostomia. The oral microbiome is a complex ecosystem of microorganisms, including bacteria, fungi, viruses, and archaea, that reside in the oral cavity. Under normal conditions, the oral microbiome is balanced, with the presence of both beneficial and potentially harmful microorganisms. However, changes in the oral environment-such as a reduction in saliva flow, altered pH levels, and increased mucosal dryness-can disrupt this balance and promote the overgrowth of pathogenic microorganisms [3].

Saliva plays a critical role in controlling the composition of the oral microbiome. Reduced salivation creates an environment conducive to the overgrowth of harmful microorganisms, including Streptococcus mutans (a bacterium responsible for dental caries) and Candida species (fungi that contribute to oral thrush). Conditions such as diabetes, hypertension, and autoimmune diseases often lead to altered immunity and reduced salivation, which can exacerbate the dysbiosis (microbial imbalance) in the oral cavity. For example, individuals with diabetes are more likely to develop fungal infections like oral candidiasis due to the higher glucose concentration in their saliva, which fuels the growth of Candida. Polypharmacy, which is common among the elderly, contributes significantly to xerostomia. Many medications, particularly antihistamines, diuretics, and antihypertensives, reduce saliva production. The resulting dry mouth leads to microbial imbalances and increases the risk of oral infections. Medications that alter the gut microbiome, such as antibiotics, can also influence the composition of the oral microbiota. As individuals age, their immune system undergoes changes that result in a decreased ability to respond to infections. This can allow pathogenic bacteria and fungi to proliferate unchecked, contributing to oral diseases such as periodontitis, dental caries, and oral candidiasis [4].

The oral consequences of xerostomia extend beyond discomfort and oral diseases. Dry mouth can impair an individual’s ability to eat and speak, leading to a decline in nutritional intake and social interaction. The resulting poor nutrition can contribute to overall frailty and increase the risk of malnutrition and dehydration. Moreover, the oral microbial dysbiosis associated with xerostomia can have systemic effects. Pathogenic bacteria from the oral cavity can enter the bloodstream through oral mucosal lesions or during eating and swallowing, potentially leading to systemic infections such as aspiration pneumonia, cardiovascular disease, and diabetes-related complications. Artificial saliva products can help alleviate the symptoms of xerostomia by providing moisture to the oral cavity. These products can reduce discomfort and improve oral function, such as swallowing and speaking [5].

Conclusion

Xerostomia is a common condition in elderly populations, often resulting from a combination of age-related factors, medication use, systemic diseases, and changes in oral microbial dynamics. The alteration of the oral microbiome in individuals with xerostomia contributes to an increased risk of oral diseases, including dental caries, periodontal disease, and oral infections. Given the profound impact of xerostomia on both oral and systemic health, it is essential to adopt a comprehensive approach to manage the condition. This includes promoting oral hygiene, managing systemic diseases, utilizing salivary substitutes, and considering medications to stimulate saliva production. Furthermore, ongoing research into the oral microbiome and its role in xerostomia offers promising avenues for developing more effective preventive and therapeutic strategies to improve the oral health and quality of life of elderly individuals suffering from this condition.

Acknowledgment

None.

Conflict of Interest

None.

References

1. Alevizos, Ilias, Changyu Zheng, Ana P. Cotrim and Shuying Liu, et al. "Late responses to adenoviral-mediated transfer of the aquaporin-1 gene for radiation-induced salivary hypofunction." Gene Ther 24 (2017): 176-186.

   Google Scholar, Crossref, Indexed at

2. Baum, Bruce J., Ilias Alevizos, Changyu Zheng and Ana P. Cotrim, et al. "Early responses to adenoviral-mediated transfer of the aquaporin-1 cDNA for radiation-induced salivary hypofunction." Proc Natl Acad Sci 109 (2012): 19403-19407.

   Google Scholar, Crossref, Indexed at

3. Lai, Zhennan, Hongen Yin, Javier Cabrera-Pérez and Maria C. Guimaro, et al. "Aquaporin gene therapy corrects Sjögren’s syndrome phenotype in mice." Proc Natl Acad Sci 113 (2016): 5694-5699.

   Google Scholar, Crossref, Indexed at

4. Palaniyandi, S., Y. Odaka, W. Green and F. Abreo, et al. "Adenoviral delivery of Tousled kinase for the protection of salivary glands against ionizing radiation damage." Gene Ther 18 (2011): 275-282.

   Google Scholar, Crossref, Indexed at

5. Strietzel, Frank P., Gloria I. Lafaurie, Gloria R. Bautista Mendoza and Ivan Alajbeg, et al. "Efficacy and safety of an intraoral electrostimulation device for xerostomia relief: A multicenter, randomized trial." Arthritis Rheumatol 63 (2011): 180-190.

   Google Scholar, Crossref, Indexed at